Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Mylan Institutional LLC v. Aurobindo Pharma Ltd., No. 17-1645 (Fed. Cir. May 19, 2017)

Affirmed in Part
Injunction Infringement Claim Construction
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-1645
Decided
May 19, 2017
Judge
Lourie, J.
Document
Precedential Opinion
Length
25 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., and Auromedics Pharma LLC (together, “Aurobindo”) appeal from a decision of t he United States District Court for the Eastern District of Texas granting Mylan Instit u- tional LLC ’s (“Mylan Inst. ”) and Apicore US LLC’s (“Apicore”) (together, “Mylan”) motion for a preliminary injunction precluding Aurobindo from making, using, selling, offering to sell , and importing the accused isosul- fan blue (“ISB”) product that allegedly infringes three of Apicore’s patents—U.S.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error